Skip to content

Omega Fund Management, LLC

Follow

13F filer, CIK 1637359, BOSTON, MA

Omega Fund Management, LLC reported $125,163,396 across 10 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16.

Accepted , ingested 13F-HR 0001193125-26-462150

Period
2026-09-30
Reported value
$125M
Holdings
10
Top 10 weight
100%
New
1
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
IMUXnew+430,180$4M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
KMTSreduced-659,755-$18.7M
ALMSexited-241,255-$6.79M
BBNXreduced-354,173-$6.72M
NUVBreduced-930,058-$5.21M
BCAXreduced-62,238-$1.16M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001193125-26-462150, largest first. % of portfolio is the value over $125,163,395, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
NUVBNUVATION BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 13,072,340 shares; 2025Q1: 13,072,340 shares; 2025Q2: 11,042,728 shares; 2025Q3: 8,831,089 shares; 2025Q4: 8,081,089 shares; 2026Q1: 8,081,089 shares; 2026Q2: 8,081,089 shares; 2026Q3: 7,151,031 shares 7,151,031$40M31.99%-930,058Timeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,204,650 shares; 2025Q1: 2,204,650 shares; 2025Q2: 2,204,650 shares; 2025Q3: 2,204,650 shares; 2025Q4: 2,204,650 shares; 2026Q1: 2,392,150 shares; 2026Q2: 1,822,150 shares; 2026Q3: 1,759,912 shares 1,759,912$32.8M26.17%-62,238Timeline
BBNXBETA BIONICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,988,287 shares; 2025Q2: 1,988,287 shares; 2025Q3: 1,920,125 shares; 2025Q4: 1,316,183 shares; 2026Q1: 1,316,183 shares; 2026Q2: 1,316,183 shares; 2026Q3: 962,010 shares 962,010$18.3M14.59%-354,173Timeline
BBOTBRIDGEBIO ONCOLOGY THERAPEUTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 3,289,661 shares; 2025Q4: 3,289,661 shares; 2026Q1: 3,289,661 shares; 2026Q2: 3,289,661 shares; 2026Q3: 3,289,661 shares 3,289,661$13.5M10.78%0Timeline
KMTSKESTRA MED TECHNOLOGIES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,795,893 shares; 2025Q2: 1,645,893 shares; 2025Q3: 1,645,893 shares; 2025Q4: 1,373,591 shares; 2026Q1: 1,022,149 shares; 2026Q2: 1,022,149 shares; 2026Q3: 362,394 shares 362,394$10.3M8.19%-659,755Timeline
IMUXIMMUNIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 430,180 shares 430,180$4M3.2%newTimeline
SANASANA BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 843,750 shares; 2025Q1: 843,750 shares; 2025Q2: 843,750 shares; 2025Q3: 843,750 shares; 2025Q4: 843,750 shares; 2026Q1: 843,750 shares; 2026Q2: 843,750 shares; 2026Q3: 843,750 shares 843,750$2.46M1.97%0Timeline
IMAIMAGENEBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 455,361 shares; 2025Q4: 455,361 shares; 2026Q1: 455,361 shares; 2026Q2: 455,361 shares; 2026Q3: 455,361 shares 455,361$2.09M1.67%0Timeline
ENGNENGENE HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 526,357 shares; 2025Q1: 526,357 shares; 2025Q2: 526,357 shares; 2025Q3: 526,357 shares; 2025Q4: 876,357 shares; 2026Q1: 876,357 shares; 2026Q2: 876,357 shares; 2026Q3: 876,357 shares 876,357$1.75M1.4%0Timeline
ODTXODYSSEY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,893 shares; 2026Q3: 2,893 shares 2,893$64.3K0.05%0Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ALMSALUMIS INC241,255$6.79Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001193125-26-462150 base2026-11-16